Home › Funds › NIXON PEABODY TRUST CO › IQV
NIXON PEABODY TRUST CO position in IQV
IQVIA HLDGS INC · Health Care
NIXON PEABODY TRUST CO reported holding 74,072 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$19.9M, representing 1.30% of its reported portfolio and ranking #18 among its reported holdings. NIXON PEABODY TRUST CO has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NIXON PEABODY TRUST CO's IQV position evolved
NIXON PEABODY TRUST CO first disclosed a stake in IQV in Q3 2023 at 9,746 shares (US$1.9M). The position peaked in Q3 2026 at 74,072 shares, worth US$19.9M. Across 13 filings, NIXON PEABODY TRUST CO increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 74,072 shares valued at US$19.9M — an increase of 863 shares quarter over quarter.. Notable position changes include a 604% increase in Q4 2023 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.75K | $1.92M | New |
| Q4 2023 | 68.58K | $15.87M | Add |
| Q1 2024 | 73.51K | $18.59M | Add |
| Q2 2024 | 73.44K | $15.53M | Hold |
| Q3 2024 | 73.87K | $17.50M | Add |
| Q4 2024 | 57.14K | $11.23M | Reduce |
| Q1 2025 | 63.82K | $11.25M | Add |
| Q2 2025 | 60.66K | $9.56M | Reduce |
| Q3 2025 | 60.77K | $11.54M | Hold |
| Q4 2025 | 59.91K | $13.51M | Reduce |
| Q1 2026 | 72.17K | $12.31M | Add |
| Q2 2026 | 73.21K | $14.15M | Add |
| Q3 2026 | 74.07K | $19.91M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IQV and 13F data
IQV (IQVIA HLDGS INC) is a Health Care company. 25 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Boston Partners (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IQV
- Harris Associates (Oakmark) 12.18M sh · $2.35B · Q2 2026
- HARRIS ASSOCIATES L P 12.18M sh · $2.35B · Q2 2026
- Boston Partners 4.37M sh · $1.17B · Q3 2026
- Artisan Partners Limited Partnership 3.46M sh · $930.59M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 2.67M sh · $717.70M · Q3 2026
- LYRICAL ASSET MANAGEMENT LP 1.25M sh · $337.08M · Q3 2026
More on NIXON PEABODY TRUST CO
FAQ
How long has NIXON PEABODY TRUST CO held IQV?
NIXON PEABODY TRUST CO has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is NIXON PEABODY TRUST CO's current position in IQV?
As of Q3 2026, NIXON PEABODY TRUST CO holds 74.07K shares of IQV (IQVIA HLDGS INC), valued at $19.91M, representing 1.30% of its reported portfolio and ranking #18.
Has NIXON PEABODY TRUST CO been buying or selling IQV?
In the latest 13F filing (Q3 2026), NIXON PEABODY TRUST CO increased its position in IQV. The position peaked in Q3 2026 at 74.07K shares.
Which other funds hold IQV?
Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Boston Partners, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.